表紙:欧州の非経口栄養の市場:栄養素の種類別・国別の展望、成長可能性、新型コロナウイルス感染症 (COVID-19) の影響の分析、将来予測 (2021年~2027年)
市場調査レポート
商品コード
1029715

欧州の非経口栄養の市場:栄養素の種類別・国別の展望、成長可能性、新型コロナウイルス感染症 (COVID-19) の影響の分析、将来予測 (2021年~2027年)

Europe Parenteral Nutrition Market By Nutrient Type, By Country, Growth Potential, COVID-19 Impact Analysis Report and Forecast, 2021 - 2027

出版日: | 発行: KBV Research | ページ情報: 英文 64 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.72円
欧州の非経口栄養の市場:栄養素の種類別・国別の展望、成長可能性、新型コロナウイルス感染症 (COVID-19) の影響の分析、将来予測 (2021年~2027年)
出版日: 2021年08月31日
発行: KBV Research
ページ情報: 英文 64 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州の非経口栄養市場は、予測期間中 (2021年~2027年) に7.7%のCAGRで成長すると考えられます。

欧州諸国では約30万人の子どもたちが、発達段階において何らかの医療目的で医療用栄養を必要としていると考えられます。また、病院に入院している成人患者の約5分の2が栄養失調であり、医療用栄養を必要としています。そのため、各国政府が栄養意識の向上を目指した取り組みを進めており、それが市場成長の大きな要因となっています。さらに、新型コロナウイルス感染症 (COVID-19) 患者には食欲不振や筋肉量減少・免疫力低下といった症状が現れるため、病院や診療所でCOVID-19患者向け<の静脈内栄養投与の需要が増加すると予想されています。

当レポートでは、欧州の非経口栄養の市場について分析し、製品の概要や市場の主な傾向、市場規模の動向見通し、栄養素の種類別および国別の詳細動向、主な市場促進・抑制要因、市場競争環境、主要企業のプロファイル、昨今の資本取引・事業戦略の展開状況、といった情報を取りまとめてお届けいたします。

目次

第1章 市場の範囲と分析手法

第2章 市場の概要

  • イントロダクション
  • 市場に影響を与える主な要因

第3章 欧州の非経口栄養市場:栄養素の種類別

  • 単回投与アミノ酸溶液
  • 非経口脂質エマルジョン
  • 炭水化物
  • 微量元素
  • その他

第4章 欧州の非経口栄養市場:国別

  • ドイツ
  • 英国
  • フランス
  • ロシア
  • スペイン
  • イタリア
  • 他の欧州諸国

第5章 企業プロファイル

  • Vifor Pharma Management Ltd.
  • Baxter International, Inc.
  • Allergan PLC(AbbVie)
  • B. Braun Melsungen AG
  • Fresenius SE & Co. KGaA
  • Grifols S.A.
  • Pfizer, Inc.
  • ICU Medical, Inc.
  • Anhui Medipharm Co., Ltd.
  • Aculife Healthcare Private Limited
図表

LIST OF TABLES

  • TABLE 1 Europe Parenteral Nutrition Market, 2017 - 2020, USD Million
  • TABLE 2 Europe Parenteral Nutrition Market, 2021 - 2027, USD Million
  • TABLE 3 Europe Parenteral Nutrition Market by Nutrient Type, 2017 - 2020, USD Million
  • TABLE 4 Europe Parenteral Nutrition Market by Nutrient Type, 2021 - 2027, USD Million
  • TABLE 5 Europe Single Dose Amino Acid Solution Market by Country, 2017 - 2020, USD Million
  • TABLE 6 Europe Single Dose Amino Acid Solution Market by Country, 2021 - 2027, USD Million
  • TABLE 7 Europe Parenteral Lipid Emulsion Market by Country, 2017 - 2020, USD Million
  • TABLE 8 Europe Parenteral Lipid Emulsion Market by Country, 2021 - 2027, USD Million
  • TABLE 9 Europe Carbohydrates Market by Country, 2017 - 2020, USD Million
  • TABLE 10 Europe Carbohydrates Market by Country, 2021 - 2027, USD Million
  • TABLE 11 Europe Trace Elements Market by Country, 2017 - 2020, USD Million
  • TABLE 12 Europe Trace Elements Market by Country, 2021 - 2027, USD Million
  • TABLE 13 Europe Other Nutrient Type Market by Country, 2017 - 2020, USD Million
  • TABLE 14 Europe Other Nutrient Type Market by Country, 2021 - 2027, USD Million
  • TABLE 15 Europe Parenteral Nutrition Market by Country, 2017 - 2020, USD Million
  • TABLE 16 Europe Parenteral Nutrition Market by Country, 2021 - 2027, USD Million
  • TABLE 17 Germany Parenteral Nutrition Market, 2017 - 2020, USD Million
  • TABLE 18 Germany Parenteral Nutrition Market, 2021 - 2027, USD Million
  • TABLE 19 Germany Parenteral Nutrition Market by Nutrient Type, 2017 - 2020, USD Million
  • TABLE 20 Germany Parenteral Nutrition Market by Nutrient Type, 2021 - 2027, USD Million
  • TABLE 21 UK Parenteral Nutrition Market, 2017 - 2020, USD Million
  • TABLE 22 UK Parenteral Nutrition Market, 2021 - 2027, USD Million
  • TABLE 23 UK Parenteral Nutrition Market by Nutrient Type, 2017 - 2020, USD Million
  • TABLE 24 UK Parenteral Nutrition Market by Nutrient Type, 2021 - 2027, USD Million
  • TABLE 25 France Parenteral Nutrition Market, 2017 - 2020, USD Million
  • TABLE 26 France Parenteral Nutrition Market, 2021 - 2027, USD Million
  • TABLE 27 France Parenteral Nutrition Market by Nutrient Type, 2017 - 2020, USD Million
  • TABLE 28 France Parenteral Nutrition Market by Nutrient Type, 2021 - 2027, USD Million
  • TABLE 29 Russia Parenteral Nutrition Market, 2017 - 2020, USD Million
  • TABLE 30 Russia Parenteral Nutrition Market, 2021 - 2027, USD Million
  • TABLE 31 Russia Parenteral Nutrition Market by Nutrient Type, 2017 - 2020, USD Million
  • TABLE 32 Russia Parenteral Nutrition Market by Nutrient Type, 2021 - 2027, USD Million
  • TABLE 33 Spain Parenteral Nutrition Market, 2017 - 2020, USD Million
  • TABLE 34 Spain Parenteral Nutrition Market, 2021 - 2027, USD Million
  • TABLE 35 Spain Parenteral Nutrition Market by Nutrient Type, 2017 - 2020, USD Million
  • TABLE 36 Spain Parenteral Nutrition Market by Nutrient Type, 2021 - 2027, USD Million
  • TABLE 37 Italy Parenteral Nutrition Market, 2017 - 2020, USD Million
  • TABLE 38 Italy Parenteral Nutrition Market, 2021 - 2027, USD Million
  • TABLE 39 Italy Parenteral Nutrition Market by Nutrient Type, 2017 - 2020, USD Million
  • TABLE 40 Italy Parenteral Nutrition Market by Nutrient Type, 2021 - 2027, USD Million
  • TABLE 41 Rest of Europe Parenteral Nutrition Market, 2017 - 2020, USD Million
  • TABLE 42 Rest of Europe Parenteral Nutrition Market, 2021 - 2027, USD Million
  • TABLE 43 Rest of Europe Parenteral Nutrition Market by Nutrient Type, 2017 - 2020, USD Million
  • TABLE 44 Rest of Europe Parenteral Nutrition Market by Nutrient Type, 2021 - 2027, USD Million
  • TABLE 45 Key Information - Vifor Pharma Management Ltd.
  • TABLE 46 Key Information - Baxter International, Inc.
  • TABLE 47 Key Information - Allergan PLC
  • TABLE 48 key Information - B. Braun Melsungen AG
  • TABLE 49 key information - Fresenius SE & Co. KGaA
  • TABLE 50 key information - Grifols S.A.
  • TABLE 51 Key Information - Pfizer, Inc.
  • TABLE 52 key information - ICU Medical, Inc.
  • TABLE 53 Key Information - Anhui Medipharm Co., Ltd.
  • TABLE 54 Key Information - ACULIFE HEALTHCARE PRIVATE LIMITED

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Recent strategies and developments: Baxter International, Inc.
目次

The Europe Parenteral Nutrition Market would witness market growth of 7.7% CAGR during the forecast period (2021-2027).

Parenteral nutrition can be administered to children as well as infants that need special nutritional management because of a disease or medical condition. Specialized Nutrition Europe (SNE) reports that approximately 300,000 children in the EU are likely to need medical nutrition for some medical purposes during the developmental phases of their life so as to promote healthy growth and development. It also notes that approximately two-fifth of the adult patients in hospitals are malnourished and need medical nutrition with an aim to better manage the malnutrition related to disease, which is expected to lower down the duration of hospital stay.

The European parenteral nutrition market would be boosted by the governments of different countries of this region is undertaking various initiatives like the national initiative of Germany with an aim to promote nutritional awareness. The consumers residing in the region are highly adopting parenteral nutrition in order to treat insufficiency of nutrition and other required elements. Thus, the regional population prefers this method significantly due to its various benefits.

In 2020, the European Society for Clinical Nutrition and Metabolism formulated the regulations regarding the nutritional management of individuals infected with the coronavirus. According to the article circulated in 2020, the coronavirus led to a significant absence of appetite along with other symptoms that result in loss of muscle mass and a weakening immune response. To tackle this situation, clinics and hospitals have increased the accessibility of healthcare facilities for patients that need nutrition based on the disease. These developments are anticipated to boost the demand & adoption of intravenous administration of nutrition in patients.

The Germany market dominated the Europe Carbohydrates Market by Country in 2020, thereby, achieving a market value of $168 million by 2027. The UK market is experiencing a CAGR of 7.3% during (2021 - 2027). Additionally, The France market is anticipated to witness a CAGR of 9.7% during (2021 - 2027).

Based on Nutrient Type, the market is segmented into Single Dose Amino Acid Solution, Parenteral Lipid Emulsion, Carbohydrates, Trace Elements, and Vitamins & Minerals. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Vifor Pharma Management Ltd., Baxter International, Inc., Allergan PLC (AbbVie), B. Braun Melsungen AG, Fresenius SE & Co. KGaA, Grifols S.A., Pfizer, Inc., ICU Medical, Inc., Anhui Medipharm Co., Ltd. and Aculife Healthcare Private Limited.

Scope of the Study

Market Segments covered in the Report:

By Nutrient Type

  • Single Dose Amino Acid Solution
  • Parenteral Lipid Emulsion
  • Carbohydrates
  • Trace Elements,
  • Vitamins & Minerals

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Companies Profiled

  • Vifor Pharma Management Ltd.
  • Baxter International, Inc.
  • Allergan PLC (AbbVie)
  • B. Braun Melsungen AG
  • Fresenius SE & Co. KGaA
  • Grifols S.A.
  • Pfizer, Inc.
  • ICU Medical, Inc.
  • Anhui Medipharm Co., Ltd.
  • Aculife Healthcare Private Limited

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Europe Parenteral Nutrition Market, by Nutrient Type
    • 1.4.2 Europe Parenteral Nutrition Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 COVID-19 Impact
      • 2.1.1.2 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Europe Parenteral Nutrition Market by Nutrient Type

  • 3.1 Europe Single Dose Amino Acid Solution Market by Country
  • 3.2 Europe Parenteral Lipid Emulsion Market by Country
  • 3.3 Europe Carbohydrates Market by Country
  • 3.4 Europe Trace Elements Market by Country
  • 3.5 Europe Other Nutrient Type Market by Country

Chapter 4. Europe Parenteral Nutrition Market by Country

  • 4.1 Germany Parenteral Nutrition Market
    • 4.1.1 Germany Parenteral Nutrition Market by Nutrient Type
  • 4.2 UK Parenteral Nutrition Market
    • 4.2.1 UK Parenteral Nutrition Market by Nutrient Type
  • 4.3 France Parenteral Nutrition Market
    • 4.3.1 France Parenteral Nutrition Market by Nutrient Type
  • 4.4 Russia Parenteral Nutrition Market
    • 4.4.1 Russia Parenteral Nutrition Market by Nutrient Type
  • 4.5 Spain Parenteral Nutrition Market
    • 4.5.1 Spain Parenteral Nutrition Market by Nutrient Type
  • 4.6 Italy Parenteral Nutrition Market
    • 4.6.1 Italy Parenteral Nutrition Market by Nutrient Type
  • 4.7 Rest of Europe Parenteral Nutrition Market
    • 4.7.1 Rest of Europe Parenteral Nutrition Market by Nutrient Type

Chapter 5. Company Profiles

  • 5.1 Vifor Pharma Management Ltd.
    • 5.1.1 Company Overview
    • 5.1.2 Financial Analysis
    • 5.1.3 Research & Development Expenses
  • 5.2 Baxter International, Inc.
    • 5.2.1 Company Overview
    • 5.2.2 Financial Analysis
    • 5.2.3 Regional Analysis
    • 5.2.4 Research & Development Expense
    • 5.2.1 Recent strategies and developments:
      • 5.2.1.1 Partnerships, Collaborations, and Agreements:
      • 5.2.1.2 Product Launches and Product Expansions:
      • 5.2.1.3 Approvals and Trails:
  • 5.3 Allergan PLC (AbbVie)
    • 5.3.1 Company Overview
    • 5.3.2 Financial Analysis
    • 5.3.3 Regional Analysis
    • 5.3.4 Research & Development Expense
  • 5.4 B. Braun Melsungen AG
    • 5.4.1 Company Overview
    • 5.4.2 Financial Analysis
    • 5.4.3 Segmental and Regional Analysis
    • 5.4.4 Research & Development Expenses
  • 5.5 Fresenius SE & Co. KGaA
    • 5.5.1 Company Overview
    • 5.5.2 Financial Analysis
    • 5.5.3 Segmental and Regional Analysis
    • 5.5.4 Research & Development Expenses
  • 5.6 Grifols S.A.
    • 5.6.1 Company Overview
    • 5.6.2 Financial Analysis
    • 5.6.3 Segmental and Regional Analysis
    • 5.6.4 Research & Development Expense
  • 5.7 Pfizer, Inc.
    • 5.7.1 Company Overview
    • 5.7.2 Financial Analysis
    • 5.7.3 Regional Analysis
    • 5.7.4 Research & Development Expenses
  • 5.8 ICU Medical, Inc.
    • 5.8.1 Company Overview
    • 5.8.2 Recent strategies and developments:
      • 5.8.2.1 Partnerships, Collaborations, and Agreements:
  • 5.9 Anhui Medipharm Co., Ltd.
    • 5.9.1 Company Overview
  • 5.10. Aculife Healthcare Private Limited
    • 5.10.1 Company Overview